A risk factor in the development of hepatocellular carcinoma: Insulin analogues. Ann Med Res [Internet]. 2022 Nov. 23 [cited 2025 May 9];29(11):1209-13. Available from: http://www.annalsmedres.org/index.php/aomr/article/view/4328